Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Weight loss results vary by individual, but in clinical studies, people taking GLP-1 Treatments, Semaglutide or Tirzepatide for weight loss have lost, on average, 10-15% of their body weight over a 6-month to 1-year period
10.1016/j.neuropharm.2018.02.027 Neuropharmacology 33 KriegerJ.-P.ArnoldM.PettersenK
The medication also enhances glucose-dependent insulin secretion and suppresses inappropriate glucagon release, contributing to improved blood glucose control
That gradual titration is deliberate
If you are ready to see if this oral option is your path to success, Book a free, no-obligation telehealth meeting (phone or video call) through our website or visit our Plans and Pricing page .
Clinical trials on Nevolat have found that patients can lose an average 8.0% of their weight in 56 weeks on the highest maintenance dosage
US$ 26.07
US$ 23.25
US$ 25.69
US$ 22.93
US$ 26.22
US$ 20.39
US$ 22.71
US$ 26.41
US$ 22.13
US$ 21.17
